Macrophage migration inhibitory factor receptor CD74 mediates alphavirus-induced arthritis and myositis in murine models of alphavirus infection

Arthritis and Rheumatism

Volumn 65, Issue 10, 2013, Pages 2724-2736

  Herrero, Lara J ^a   Sheng, Kuo Ching ^a   Jian, Peng ^a   Taylor, Adam ^a   Her, Zhisheng ^b   Herring, Belinda L ^a   Chow, Angela ^c   Leo, Yee Sin ^c   Hickey, Michael J ^d   Morand, Eric F ^d   Ng, Lisa F P ^b   Bucala, Richard ^e   Mahalingam, Suresh ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c TAN TOCK SENG HOSPITAL   (Singapore)

^d MONASH UNIVERSITY   (Australia)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD74 ANTIGEN; CHEMOKINE; MACROPHAGE MIGRATION INHIBITION FACTOR;

ALPHAVIRUS INFECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTHRITIS; ARTICLE; CELL INFILTRATION; CELL MIGRATION; CELL SURVIVAL; CHIKUNGUNYA; CHIKUNGUNYA ALPHAVIRUS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATION; LEUKOCYTE; MONOCYTE; MOUSE; MYOSITIS; NATURAL KILLER CELL; NONHUMAN; POLYARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUADRICEPS FEMORIS MUSCLE; REAL TIME POLYMERASE CHAIN REACTION; ROSS RIVER ALPHA VIRUS; TISSUE INJURY; UPREGULATION;

EID: 84885088472     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Suhrbier A, La Linn M,. Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses. Curr Opin Rheumatol 2004; 16: 374-9.
2. Rulli NE, Melton J, Wilmes A, Ewart G, Mahalingam S,. The molecular and cellular aspects of arthritis due to alphavirus infections: lesson learned from Ross River virus. Ann N Y Acad Sci 2007; 1102: 96-108.
3. Suhrbier A, Mahalingam S,. The immunobiology of viral arthritides. Pharmacol Ther 2009; 124: 301-8.
4. Renault P, Solet JL, Sissoko D, Balleydier E, Larrieu S, Filleul L, et al. A major epidemic of chikungunya virus infection on Reunion Island, France, 2005-2006. Am J Trop Med Hyg 2007; 77: 727-31.
5. Burt FJ, Rolph MS, Rulli NE, Mahalingam S, Heise MT,. Chikungunya: a re-emerging virus. Lancet 2012; 379: 662-71.
6. Josseran L, Paquet C, Zehgnoun A, Caillere N, Le Tertre A, Solet JL, et al. Chikungunya disease outbreak, Reunion Island. Emerg Infect Dis 2006; 12: 1994-5.
7. Kalantri SP, Joshi R, Riley LW,. Chikungunya epidemic: an Indian perspective. Natl Med J India 2006; 19: 315-22.
8. Yergolkar PN, Tandale BV, Arankalle VA, Sathe PS, Sudeep AB, Gandhe SS, et al. Chikungunya outbreaks caused by African genotype, India. Emerg Infect Dis 2006; 12: 1580-3.
9. Kelvin AA,. Outbreak of Chikungunya in the Republic of Congo and the global picture. J Infect Dev Ctries 2011; 5: 441-4.
10. Setepano N,. New disease enters PNG. Post-Curier Online 2012. URL: http://www.postcourier.com.pg/20121010/news09.htm.
11. Flores H,. Cases of dengue-like virus rising. Philippine Star 2012. URL: http://www.philstar.com/headlines/2012/10/09/857603/doh-cases-dengue-virus- rising.
12. Chaves TS, Pellini AC, Mascheretti M, Jahnel MT, Ribeiro AF, Rodrigues SG, et al. Travelers as sentinels for chikungunya fever, Brazil. Emerg Infect Dis 2012; 18: 529-30.
13. Ruiz-Moreno D, Vargas IS, Olson KE, Harrington LC,. Modeling dynamic introduction of chikungunya virus in the United States. PLoS Negl Trop Dis 2012; 6: e1918.
14. Harley D, Sleigh A, Ritchie S,. Ross River virus transmission, infection, and disease: a cross-disciplinary review. Clin Microbiol Rev 2001; 14: 909-32.
15. Lidbury BA, Simeonovic C, Maxwell GE, Marshall ID, Hapel AJ,. Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice. J Infect Dis 2000; 181: 27-34.
16. Lidbury BA, Rulli NE, Suhrbier A, Smith PN, McColl SR, Cunningham AL, et al. Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis 2008; 197: 1585-93.
17. Morrison TE, Fraser RJ, Smith PN, Mahalingam S, Heise MT,. Complement contributes to inflammatory tissue destruction in a mouse model of Ross River virus-induced disease. J Virol 2007; 81: 5132-43.
18. Morrison TE, Whitmore AC, Shabman RS, Lidbury BA, Mahalingam S, Heise MT,. Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J Virol 2006; 80: 737-49.
19. Gunn BM, Morrison TE, Whitmore AC, Blevins LK, Hueston L, Fraser RJ, et al. Mannose binding lectin is required for alphavirus-induced arthritis/myositis. PLoS Pathog 2012; 8: e1002586.
20. Neighbours LM, Long K, Whitmore AC, Heise MT,. Myd88-dependent TLR7 signaling mediates protection from severe Ross River virus-induced disease in mice. J Virol 2012; 86: 19675-85.
21. Herrero LJ, Nelson M, Srikiatkhachorn A, Gu R, Anantapreecha S, Fingerle-Rowson G, et al. Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis. Proc Natl Acad Sci U S A 2011; 108: 12048-53.
22. Calandra T, Roger T,. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003; 3: 791-800.
23. Borghese F, Clanchy FI,. CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease. Expert Opin Ther Targets 2011; 15: 237-51.
24. Gore Y, Starlets D, Maharshak N, Becker-Herman S, Kaneyuki U, Leng L, et al. Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J Biol Chem 2008; 283: 2784-92.
25. Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, et al. MIF signal transduction initiated by binding to CD74. J Exp Med 2003; 197: 1467-76.
26. Lue H, Dewor M, Leng L, Bucala R, Bernhagen J,. Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74. Cell Signal 2011; 23: 135-44.
27. Shi X, Leng L, Wang T, Wang W, Du X, Li J, et al. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 2006; 25: 595-606.
28. Binsky I, Haran M, Starlets D, Gore Y, Lantner F, Harpaz N, et al. IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival. Proc Natl Acad Sci U S A 2007; 104: 13408-13.
29. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 2007; 13: 587-96.
30. Fan H, Hall P, Santos LL, Gregory JL, Fingerle-Rowson G, Bucala R, et al. Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase. J Immunol 2011; 186: 4915-24.
31. Schwartz V, Lue H, Kraemer S, Korbiel J, Krohn R, Ohl K, et al. A functional heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Lett 2009; 583: 2749-57.
32. Kuhn RJ, Niesters HG, Hong Z, Strauss JH,. Infectious RNA transcripts from Ross River virus cDNA clones and the construction and characterization of defined chimeras with Sindbis virus. Virology 1991; 182: 430-41.
33. Chow A, Her Z, Ong EK, Chen JM, Dimatatac F, Kwek DJ, et al. Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis 2011; 203: 149-57.
34. Teng TS, Foo SS, Simamarta D, Lum FM, Teo TH, Lulla A, et al. Viperin restricts chikungunya-virus replication and pathology J Clin Invest 2012; 122: 4447-60.
35. Kam YW, Simarmata D, Chow A, Her Z, Teng TS, Ong EK, et al. Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection. J Infect Dis 2012; 205: 1147-54.
36. Fingerle-Rowson G, Petrenko O, Metz CN, Forsthuber TG, Mitchell R, Huss R, et al. The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc Natl Acad Sci U S A 2003; 100: 9354-9.
37. Gardner J, Anraku I, Le TT, Larcher T, Major L, Roques P, et al. Chikungunya virus arthritis in adult wild-type mice. J Virol 2010; 84: 8021-32.
38. Hoarau JJ, Jaffar Bandjee MC, Krejbich Trotot P, Das T, Li-Pat-Yuen G, Dassa B, et al. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol 2010; 184: 5914-27.
39. + T cell selection in mice lacking invariant chain expression. J Exp Med 1993; 177: 1699-712.
40. Topilski I, Harmelin A, Flavell RA, Levo Y, Shachar I,. Preferential Th1 immune response in invariant chain-deficient mice. J Immunol 2002; 168: 1610-7.
41. Zaidi T, Reidy T, D'Ortona S, Fichorova R, Pier G, Gadjeva M,. CD74 deficiency ameliorates Pseudomonas aeruginosa-induced ocular infection. Sci Rep 2011; 1: 58.
42. Toh ML, Aeberli D, Lacey D, Yang Y, Santos LL, Clarkson M, et al. Regulation of IL-1 and TNF receptor expression and function by endogenous macrophage migration inhibitory factor. J Immunol 2006; 177: 4818-25.
43. Rossi AG, Haslett C, Hirani N, Greening AP, Rahman I, Metz CN, et al. Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF): potential role in asthma. J Clin Invest 1998; 101: 2869-74.
44. Riedemann NC, Guo RF, Gao H, Sun L, Hoesel M, Hollmann TJ, et al. Regulatory role of C5a on macrophage migration inhibitory factor release from neutrophils. J Immunol 2004; 173: 1355-9.
45. Morrison TE, Simmons JD, Heise MT,. Complement receptor 3 promotes severe Ross River virus-induced disease. J Virol 2008; 82: 11263-72.
46. Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci U S A 2002; 99: 345-50.
47. Kim HJ, Lee YH, Im SA, Kim K, Lee CK,. Cyclooxygenase inhibitors, aspirin and ibuprofen, inhibit MHC-restricted antigen presentation in dendritic cells. Immune Netw 2010; 10: 92-8.
48. Bancos S, Bernard MP, Topham DJ, Phipps RP,. Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cells. Cell Immunol 2009; 258: 18-28.